Details for New Drug Application (NDA): 085571
✉ Email this page to a colleague
NDA 085571 describes GLUTETHIMIDE, which is a drug marketed by Halsey, Lannett, Ucb Inc, Upsher Smith Labs, Vitarine, and Watson Labs, and is included in nine NDAs. Additional details are available on the GLUTETHIMIDE profile page.
The generic ingredient in GLUTETHIMIDE is glutethimide. There are four drug master file entries for this compound. Additional details are available on the glutethimide profile page.
The generic ingredient in GLUTETHIMIDE is glutethimide. There are four drug master file entries for this compound. Additional details are available on the glutethimide profile page.
Summary for 085571
| Tradename: | GLUTETHIMIDE |
| Applicant: | Lannett |
| Ingredient: | glutethimide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085571
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
